Bio-hydrogel from RGD peptide/chitosan/β-glycerophosphate prevents postoperative wound adhesion.

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Surgical Innovation

Background:

• Postoperative adhesions occur in up to 90% of abdominal surgeries, potentially leading to fatal complications.
• Current anti-adhesion methods, like short-gelation hydrogels, have limitations including allergic reactions and rapid absorption, hindering long-term recovery.
• There is a need for advanced anti-adhesion solutions that offer sustained efficacy and promote wound healing.

Purpose of the Study:

• To develop and evaluate a novel, long-lasting, temperature-sensitive hydrogel for preventing postoperative adhesions.
• To assess the hydrogel's biocompatibility, anti-adhesion efficacy, and tissue proliferation capabilities.
• To investigate the molecular mechanisms underlying the hydrogel's anti-fibrotic effects.

Main Methods:

• Development of a temperature-sensitive hydrogel incorporating arginyl-glycyl-aspartic acid, forming at 37°C.
• In vitro cell testing and in vivo animal studies to evaluate biocompatibility and anti-adhesion performance.
• Analysis of the hydrogel's degradation profile (50% in 7 days) and its impact on fibrotic pathways (SMAD, P38, PI3K, TGF-β).

Main Results:

• The developed hydrogel demonstrated excellent biocompatibility in cell and animal models.
• Effective prevention of adhesion formation after abdominal surgery was confirmed in animal experiments.
• The hydrogel significantly boosted tissue proliferation and promoted histoarchitecture remodeling by inhibiting TGF-β signaling and reducing fibrosis.

Conclusions:

• The long-lasting, temperature-sensitive hydrogel presents a promising new option for preventing postoperative adhesions.
• Its ability to inhibit fibrosis and promote tissue regeneration offers versatile applications in medical treatments.
• This innovative hydrogel addresses limitations of current anti-adhesion products, paving the way for future medical uses.